IP Verse

Szynka patent opposition analysis

The comprehensive analysis of Szynka opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Szynka

Stay updated with the latest patent oppositions filed by Szynka

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3819007
Dosing Regimen For Anti-Bcma AgentsAMGEN RESEARCH (MUNICH) GMBHApr 9, 2025ABBVIE
EP3747464
 - Mar 26, 2025HEXAL
EP3669338
Passive Care Control Method And Associated SystemsMICAS AGJan 24, 2025GEBERIT
EP4058148
Dosing Regimen For Anti-Bcma AgentsAMGEN RESEARCH (MUNICH) GMBHDec 13, 2024ABBVIE
EP4209499
Charged Depth Filtration Of Antigen-Binding ProteinsAMGEN INC.Sep 23, 2024HEMSATH
EP3880089
Shock Wave Apparatus And Method For Treating A Human Or Animal BodyFERTON HOLDING S.A.Sep 13, 2024STORZ MEDICAL
EP3823992
Anti-Lypd3 Car T-Cell Therapy For The Treatment Of CancerDUKE UNIVERSITYSep 12, 2024HEMSATH
EP3814496
Sample Preparation Method And SystemGEN-PROBE INCORPORATEDAug 22, 2024QIAGEN
EP3334747
Charged Depth Filtration Of Antigen-Binding ProteinsAMGEN INC.Jun 27, 2024HEMSATH
EP3631454
Treatment Of Lag-3 Positive TumorsBRISTOL-MYERS SQUIBB COMPANYJun 3, 2024ROTH

Top clients of Szynka

Top companies who are the clients of Szynka

CompanyTotal
KONIG SZYNKA TILMANN VON RENESSE27
GEBERIT20
HAUFF TECHNIK10
QIAGEN9
ABBVIE6
ROTH4
HEXAL3
HEMSATH3
MSG MASCHINENBAU2
BAYER2